Abstract:With the process of oral submucous fibrosis, the expression level of Collagen increased with rising inflammatory response. In vitro experiments also demonstrate that IGF‐1, the activator of Pi3k/Akt pathway promoted proliferation and migration of huvecs while LY294004, the inhibitor, exhibited the opposite function. Oral submucous fibrosis (OSF) has a high incidence in Asia countries, but its underlying molecular mechanism was not exploited completely. In this research, we investigated the expression of the phosphatidyl inositol 3‐kinase (Pi3k)/protein kinase B (Akt) pathway and vascular endothelial growth factor (VEGF) in oral submucosal fibrosis, explore the correlation between the Pi3k/Akt pathway and VEGF, and identify the mechanisms involved in OSF. The pathological changes and fibrosis stages of OSF tissues (n = 30, 10 each of early, moderate and advanced OSF) were determined using Haematoxylin–eosin staining (HE) and Masson staining, respectively. Collagen type I (Col‐I), Pi3k, Akt, VEGF, TGF‐β and p‐Akt expression was detected using immunohistochemistry, qPCR and WB. The correlation between Pi3k, Akt and VEGF was analysed. Col‐I expression increased as OSF progressed. However, their expression was downregulated in normal and moderate to advanced OSF tissues. VEGF expression positively correlated with Pi3k and Akt expression. VEGF expression correlated positively and negatively with the Pi3k inhibitor, LY294002 below and above a concentration of 10 μM, respectively. VEGF expression correlated positively with the Pi3k/Ak activator, IGF‐1. Due to the synergistic effect between Pi3k/Akt pathway and VEGF on OSF lesions and fibrosis process, targeted Pi3k/Akt pathway regulation can induce VEGF expression and improve ischemia, ultimately treating OSF.

Autophagy Mediates Oral Submucous Fibrosis.

Etiology, pathogenesis, diagnosis and treatment of oral submucous fibrosis

Immunopathogenesis of oral submucous fibrosis by chewing the areca nut

Discovery of Novel Biomarkers in Oral Submucous Fibrosis by Microarray Analysis

Experimental Study on TGF‐β1‐mediated CD147 Expression in Oral Submucous Fibrosis

Mechanisms and markers of malignant transformation of oral submucous fibrosis

Gene Expression Profiling of Oral Submucous Fibrosis Using Oligonucleotide Microarray

Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis

Cyclophilin A Was Revealed As a Candidate Marker for Human Oral Submucous Fibrosis by Proteomic Analysis.

Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis

Role of Areca-nut on the Pathogenesis of Oral Submucous Fibrosis

Senescent Epithelial Cells Remodel the Microenvironment for the Progression of Oral Submucous Fibrosis Through Secreting TGF-(31

DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis

Expression and correlation of the Pi3k/Akt pathway and <scp>VEGF</scp> in oral submucous fibrosis

MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis

Identification of a BRAF/PA28γ/MEK1 Signaling Axis and Its Role in Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis

YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.

Exosomal Mir-17-5p Derived from Epithelial Cells is Involved in Aberrant Epithelium-Fibroblast Cross-Talk and Induces the Development of Oral Submucosal Fibrosis

Expression and correlation of the Pi3k/Akt pathway and VEGF in oral submucous fibrosis

Cys–X–Cys Ligand 9 Might Be an Immunological Factor in the Pathogenesis of Oral Submucous Fibrosis and Its Concomitant Oral Lichenoid Lesion

PTMA, a New Identified Autoantigen for Oral Submucous Fibrosis, Regulates Oral Submucous Fibroblast Proliferation and Extracellular Matrix.